These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609 [TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431 [TBL] [Abstract][Full Text] [Related]
6. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum. Lee JB; Hayashi K; Hayashi T; Sankawa U; Maeda M Planta Med; 1999 Jun; 65(5):439-41. PubMed ID: 10418331 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture. Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844 [TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Albiol Matanic VC; Castilla V Int J Antimicrob Agents; 2004 Apr; 23(4):382-9. PubMed ID: 15081088 [TBL] [Abstract][Full Text] [Related]
9. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636 [TBL] [Abstract][Full Text] [Related]
11. The synergistic effects of betulin with acyclovir against herpes simplex viruses. Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608 [TBL] [Abstract][Full Text] [Related]
12. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. Cheng HY; Lin TC; Yang CM; Wang KC; Lin LT; Lin CC J Antimicrob Chemother; 2004 Apr; 53(4):577-83. PubMed ID: 14998984 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2. Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of chikusetsusaponin IVa isolated from Alternanthera philoxeroides for its potency against viral replication. Rattanathongkom A; Lee JB; Hayashi K; Sripanidkulchai BO; Kanchanapoom T; Hayashi T Planta Med; 2009 Jun; 75(8):829-35. PubMed ID: 19277947 [TBL] [Abstract][Full Text] [Related]
15. Virucidal activity of a beta-triketone-rich essential oil of Leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture. Reichling J; Koch C; Stahl-Biskup E; Sojka C; Schnitzler P Planta Med; 2005 Dec; 71(12):1123-7. PubMed ID: 16395648 [TBL] [Abstract][Full Text] [Related]
16. [A new oxa-analog of myristic acid, suppressing replication of the human immunodeficiency virus]. Vodovozova EL; Mikhalev II; Rzhaninova AA; Garaev MM; Molotkovskiĭ IuG Bioorg Khim; 1995 Sep; 21(9):724-30. PubMed ID: 8588818 [TBL] [Abstract][Full Text] [Related]
17. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus. Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170 [TBL] [Abstract][Full Text] [Related]
18. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607 [TBL] [Abstract][Full Text] [Related]
19. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. Celum CL; Robinson NJ; Cohen MS J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220 [TBL] [Abstract][Full Text] [Related]